Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of PSivida patents

List of PSivida patents

List of Damaka Inc. patents

List of Xenogen patents

List of Spectraseis patents

List of founders from Berkeley, California

List of SBIR/STTR awards granted to 490 BIOTECH INC

Patents where

Current Assignee

Name

is

PSivida

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 7998108 Injector apparatus and method of use	Patent 7998108 was granted and assigned to PSivida on August, 2011 by the United States Patent and Trademark Office.		PSivida		United States Patent and Trademark Office	7998108	August 16, 2011
	‌ US Patent 7279175 Stent coated with a sustained-release drug delivery and method for use thereof	Patent 7279175 was granted and assigned to PSivida on October, 2007 by the United States Patent and Trademark Office.		PSivida		United States Patent and Trademark Office	7279175	October 9, 2007
	‌ US Patent 8192408 Ocular trocar assembly	Patent 8192408 was granted and assigned to PSivida on June, 2012 by the United States Patent and Trademark Office.		PSivida		United States Patent and Trademark Office	8192408	June 5, 2012
	‌ US Patent 8871241 Injectable sustained release delivery devices	Patent 8871241 was granted and assigned to PSivida on October, 2014 by the United States Patent and Trademark Office.		PSivida		United States Patent and Trademark Office	8871241	October 28, 2014
	‌ US Patent 8790293 Injector apparatus with fixed plunger and method of use	Patent 8790293 was granted and assigned to PSivida on July, 2014 by the United States Patent and Trademark Office.	PSivida	PSivida		United States Patent and Trademark Office	8790293	July 29, 2014
	‌ US Patent 9486459 Porous silicon drug-eluting particles	Patent 9486459 was granted and assigned to PSivida on November, 2016 by the United States Patent and Trademark Office.	PSivida	PSivida		United States Patent and Trademark Office	9486459	November 8, 2016
	‌ US Patent 9023896 Porous silicon drug-eluting particles	Patent 9023896 was granted and assigned to PSivida on May, 2015 by the United States Patent and Trademark Office.		PSivida		United States Patent and Trademark Office	9023896	May 5, 2015
	‌ US Patent 9962396 Porous silicon drug-eluting particles	Patent 9962396 was granted and assigned to PSivida on May, 2018 by the United States Patent and Trademark Office.	PSivida	PSivida		United States Patent and Trademark Office	9962396	May 8, 2018
	‌ US Patent 9333173 Bioerodible silicon-based devices for delivery of therapeutic agents	Patent 9333173 was granted and assigned to PSivida on May, 2016 by the United States Patent and Trademark Office.		PSivida		United States Patent and Trademark Office	9333173	May 10, 2016
	‌ US Patent 9808421 Bioerodible silicon-based devices for delivery of therapeutic agents	Patent 9808421 was granted and assigned to PSivida on November, 2017 by the United States Patent and Trademark Office.	PSivida	PSivida		United States Patent and Trademark Office	9808421	November 7, 2017
	‌ US Patent 9849085 Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof	Patent 9849085 was granted and assigned to PSivida on December, 2017 by the United States Patent and Trademark Office.	PSivida	PSivida		United States Patent and Trademark Office	9849085	December 26, 2017
	‌ US Patent 9192579 Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof	Patent 9192579 was granted and assigned to PSivida on November, 2015 by the United States Patent and Trademark Office.	PSivida	PSivida		United States Patent and Trademark Office	9192579	November 24, 2015
	‌ US Patent 9566336 In situ gelling drug delivery system	Patent 9566336 was granted and assigned to PSivida on February, 2017 by the United States Patent and Trademark Office.	PSivida	PSivida		United States Patent and Trademark Office	9566336	February 14, 2017
	‌ US Patent 8815284 Bioerodible sustained release drug delivery systems	Patent 8815284 was granted and assigned to PSivida on August, 2014 by the United States Patent and Trademark Office.		PSivida		United States Patent and Trademark Office	8815284	August 26, 2014
	‌ US Patent 9603801 Bioerodible silicon-based compositions for delivery of therapeutic agents	Patent 9603801 was granted and assigned to PSivida on March, 2017 by the United States Patent and Trademark Office.		PSivida		United States Patent and Trademark Office	9603801	March 28, 2017
	‌ US Patent 9980911 Bioerodible silicon-based compositions for delivery of therapeutic agents	Patent 9980911 was granted and assigned to PSivida on May, 2018 by the United States Patent and Trademark Office.		PSivida		United States Patent and Trademark Office	9980911	May 29, 2018
	‌ US Patent 8252307 Method for treating and/or preventing retinal diseases with sustained release corticosteroids	Patent 8252307 was granted and assigned to PSivida on August, 2012 by the United States Patent and Trademark Office.		PSivida		United States Patent and Trademark Office	8252307	August 28, 2012
	‌ US Patent 8574613 Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof	Patent 8574613 was granted and assigned to PSivida on November, 2013 by the United States Patent and Trademark Office.		PSivida		United States Patent and Trademark Office	8574613	November 5, 2013
	‌ US Patent 8574659 Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof			PSivida		United States Patent and Trademark Office	8574659	November 5, 2013

19 results

0 selected

19 results

0 selected